Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia

Saved in:
Bibliographic Details
Published inLeukemia Vol. 29; no. 10; pp. 2104 - 2107
Main Authors Walter, R B, Othus, M, Paietta, E M, Racevskis, J, Fernandez, H F, Lee, J-W, Sun, Z, Tallman, M S, Patel, J, Gönen, M, Abdel-Wahab, O, Levine, R L, Estey, E H
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.10.2015
Nature Publishing Group
Subjects
631/1647/2217/2018
692/420/2489/68
692/699/1541/1990/283/1897
692/699/67/1059/2326
692/699/67/1990/283/1897
Acute myeloid leukemia
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biomarkers, Tumor - genetics
Cancer Research
Cohort Studies
Critical Care Medicine
Cytarabine - administration & dosage
Daunorubicin - administration & dosage
Drug resistance
Drug Resistance, Neoplasm - genetics
Female
Follow-Up Studies
Gene Expression Profiling
Gene mutations
Genetic aspects
Genetic screening
Health aspects
Hematology
Humans
Identification and classification
Intensive
Internal Medicine
letter-to-the-editor
Leukemia
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - genetics
Leukemia, Myeloid, Acute - mortality
Male
Medicine
Medicine & Public Health
Methods
Middle Aged
Myeloid leukemia
Neoplasm Recurrence, Local - drug therapy
Neoplasm Recurrence, Local - genetics
Neoplasm Recurrence, Local - mortality
Neoplasm Staging
Oncology
Prognosis
Survival Rate
Young Adult
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2015.76